Find a Tender · Tender
Next Generation Sequencing Testing (NGS)
A public procurement published by NHS Blood and Transplant via Find a Tender.
- —
- Award value
- £600k
- Tender value
- 0
- Suppliers
- 0
- Awards
- 3
- Notices
- Tender
- Stage
Overview
NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
Key details
- Source
- Find a Tender
- Lifecycle stage
- Tender
- Status
- planning
- CPV classification
- —
- Currency
- GBP
- Total award value
- —
- Tender value
- £600,000
- First published
- 15 May 2025
- Last updated
- 26 Jan 2026
Notice timeline
Every published notice in this procurement's lifecycle.
Frameworks & programmes
More from NHS Blood and Transplant
FAQs about this procurement
Who is the buyer for "Next Generation Sequencing Testing (NGS)"?
Next Generation Sequencing Testing (NGS) is a UK public-sector procurement published by NHS Blood and Transplant via Find a Tender.
Has "Next Generation Sequencing Testing (NGS)" been awarded?
No award has been recorded yet. The current lifecycle stage is "Tender".
What is "Next Generation Sequencing Testing (NGS)" worth?
The reported tender value is £600,000.
When was "Next Generation Sequencing Testing (NGS)" published?
It was first published on 15 May 2025 and last updated on 26 Jan 2026, across 3 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable